The present results highlight that in T2DM patients systemically treated with statins, levels of pro-inflammatory factors IL-1β, IL-6 and TNF-α were elevated in GCF, whilst the anti-inflammatory factor IL-10 was downregulated compared with T2DM patients not taking statins. This evidence concerns the gene IL1B and type 2 diabetes mellitus.